Sidra Medicine signs MoU with Microsoft to achieve digital transformation goals in research

Sidra Medicine signs MoU with Microsoft to achieve digital transformation goals in research

Doha, Qatar: Sidra Medicine has signed a memorandum of understanding (MoU) with Microsoft to facilitate its research division’s digital transformation goals and accelerate its precision medicine and genomics research programs.

The MoU was signed at Microsoft Qatar’s Lusail office, by Dr. Khalid Fakhro, the Chief Research Officer from Sidra Medicine and Lana Khalaf, General Manager of Microsoft Qatar in the presence of representatives from both entities.

The MoU signals a series of strategic collaborations and implementations that will enable Sidra Medicine’s research division to expedite its technology and cloud adoption on Microsoft’s platforms, towards a complete digital transformation.

Dr. Khalid Fakhro, Chief Research Officer from Sidra Medicine, said, “The MoU with Microsoft is the start of an exciting collaborative journey with a trusted and cutting-edge technology leader, that will enable us to offer innovative solutions to research challenges. The partnership comes at an opportune time, as we are scaling up our genomics research capabilities to meet growing local and global demands. It is part of our positioning strategy to become a leading healthcare and research facility and a benchmark for precision medicine and personalised healthcare.”

The transformation, which will be led by Sidra Medicine’s Digital Health team (Research), will use Microsoft Cloud to safely